DiaMedica Therapeutics Inc. (DMAC)
NASDAQ: DMAC · Real-Time Price · USD
3.980
-0.320 (-7.44%)
At close: Jul 16, 2025, 4:00 PM
4.130
+0.150 (3.77%)
After-hours: Jul 16, 2025, 6:31 PM EDT
DiaMedica Therapeutics Analyst Ratings
Total Analysts
2
Consensus Rating
Strong Buy
Price Target
$8.00
Upside
+101.01%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $10 | Strong Buy | Reiterates | $10 | +151.26% | May 29, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $7 → $10 | Strong Buy | Maintains | $7 → $10 | +151.26% | Mar 19, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $7 | Strong Buy | Reiterates | $7 | +75.88% | Nov 15, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $7 | Strong Buy | Reiterates | $7 | +75.88% | Oct 10, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $7 | Strong Buy | Initiates | $7 | +75.88% | Oct 7, 2024 |
| Oppenheimer | Oppenheimer | Buy Reiterates $6 | Buy | Reiterates | $6 | +50.75% | Aug 16, 2024 |
| Craig-Hallum | Craig-Hallum | Strong Buy Initiates $8 | Strong Buy | Initiates | $8 | +101.01% | Apr 24, 2024 |
| Craig-Hallum | Craig-Hallum | Strong Buy Maintains $11 → $8 | Strong Buy | Maintains | $11 → $8 | +101.01% | Mar 21, 2024 |
| Oppenheimer | Oppenheimer | Buy Reiterates $7 → $6 | Buy | Reiterates | $7 → $6 | +50.75% | Mar 21, 2024 |
| Oppenheimer | Oppenheimer | Hold → Buy Upgrades $7 | Hold → Buy | Upgrades | $7 | +75.88% | Jun 22, 2023 |
| Lake Street | Lake Street | Strong Buy Maintains $14 → $8 | Strong Buy | Maintains | $14 → $8 | +101.01% | Jul 7, 2022 |
| Craig-Hallum | Craig-Hallum | Strong Buy Maintains $18 → $12 | Strong Buy | Maintains | $18 → $12 | +201.51% | Jul 7, 2022 |
| Oppenheimer | Oppenheimer | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Jul 7, 2022 |
| Roth Capital | Roth Capital | Strong Buy Maintains $38 → $32 | Strong Buy | Maintains | $38 → $32 | +704.02% | Jun 30, 2021 |
| Oppenheimer | Oppenheimer | Buy Initiates $27 | Buy | Initiates | $27 | +578.39% | Apr 8, 2021 |
| Roth Capital | Roth Capital | Strong Buy Initiates $38 | Strong Buy | Initiates | $38 | +854.77% | Feb 17, 2021 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.